| Print
LB Pharmaceuticals Inc (LBRX)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatmentof neuropsychiatric diseases, including schizophrenia.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| LB Pharmaceuticals Inc Annual Report for 2027 | 2027-03-26T00:00:00 |
| LB Pharmaceuticals Inc Annual Report for 2026 | 2027-03-26T00:00:00 |
| LB Pharmaceuticals Inc Fourth Quarter Earnings Results for 2026 | 2027-02-26T00:00:00 |
| LB Pharmaceuticals Inc Third Quarter Earnings Results for 2026 | 2026-11-30T00:00:00 |
| LB Pharmaceuticals Inc Second Quarter Earnings Results for 2026 | 2026-08-31T00:00:00 |
| LB Pharmaceuticals Inc First Quarter Earnings Results for 2026 | 2026-05-29T00:00:00 |
| LB Pharmaceuticals Inc Annual General Meeting for 2026 | 2026-04-30T00:00:00 |
| 25th Annual Needham Virtual Healthcare Conference | 2026-04-16T11:45:00 |
Previous key dates
| Name | Key Date |
|---|---|
| LB Pharmaceuticals Inc Annual General Meeting for 2026 | 2026-04-30T00:00:00 |
| 25th Annual Needham Virtual Healthcare Conference | 2026-04-16T11:45:00 |
| LB Pharmaceuticals Inc Annual Report for 2025 | 2026-03-26T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.